Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 651 of 1,261
  1. US 9556191

    Aminoquinazoline derivatives and their salts and methods of use thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  2. US 9556131

    Compositions, methods of use, and methods of treatment

    The Regents of the University of California · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  3. US 9556113

    Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment

    SOUTH DAKOTA BOARD OF REGENTS · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  4. US 9555112

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  5. US 9554987

    Methods and formulations for treating sialic acid deficiencies

    Ultragenyx Pharmaceutical Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  6. US 9555100

    Herpes virus vaccine and methods of use

    The Regents of the University of California · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  7. US 9555090

    Equine encephalitis virus vaccines and methods of using thereof

    The United States of America as repesented by the Secretary of Army, on behalf of the U.S. Army Medical Research Institute of Infections Diseases · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  8. US 9555016

    Lytic agents for use in treating intravascular clots

    Covidien LP · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  9. US 9555004

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  10. US 9554587

    Anti-regurgitation composition maintaining gut motility

    UNITED PHARMACEUTICALS · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  11. US 9554563

    Genetically modified mice and engraftment

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  12. US 9556133

    Polycyclic LPA1 antagonist and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  13. US 9554999

    Lyophilization of synthetic liposomal pulmonary surfactant

    Windtree Therapeutics, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  14. US 9556146

    Lanthionine synthetase C-like 2-based therapeutics

    Biotherapeutics, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  15. US 9555159

    Inorganically surface-modified polymers and methods for making and using them

    The Regents of the University of California · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  16. US 9556130

    4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139

    Takeda Pharmaceutical Company Limited · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  17. US 9555135

    Cobalt-based MRI contrast agent and imaging system

    The Board of Regents of the University of Texas System · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  18. US 9555114

    Methods for in vivo drug delivery with porous nanostructures

    The Regents of the University of California · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  19. US 9555099

    Vaccines for HSV-2

    IMMUNE DESIGN CORP. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  20. US 9555086

    Compositions and methods for inducing an immune response

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  21. US 9555074

    Annexin II compositions

    Regents of the University of Minnesota · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  22. US 9556244

    Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  23. US 9556232

    Anti-angiogenic molecules, nanostructures and uses thereof

    Northwestern University · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted
  24. US 9555073

    Use of vitelline protein B as a microencapsulating additive

    The Regents of the University of California · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.